MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Behavioral abnormalities"

  • 2024 International Congress

    Gender Disparities in Quality of Life Domains Among Hispanic Individuals with Parkinson’s Disease: A Comparative Analysis

    D. Bustamante-Mieles, C. Rodriguez-Alarcon, D. Piana-Castillo, G. Faggioni-Sanchez, C. Cevallos-Velasco, M. Barreiro-Guillén, R. Santibanez-Vasquez (Guayaquil, Ecuador)

    Objective: This study aims to determine gender differences in the quality of life of Parkinson's disease (PD) among Hispanic individuals. Background: PD profoundly affects various…
  • 2024 International Congress

    Visual Temporal Discrimination Threshold using a Virtual Reality Paradigm in Cervical Dystonia

    SR. Bostan, B. Lim, C. Fearon, R. Reilly (Dublin, Ireland)

    Objective: To develop a Virtual Reality (VR) application to test temporal discrimination thresholds in cervical dystonia patients within an outpatient environment. Background: Temporal discrimination threshold…
  • 2024 International Congress

    Dysfluent Writing Behavior Associates with Reduced Striatal-cerebellar Connectivity in Writer’s Cramp Dystonia

    Z. Simsek, M. Lipp, S. Groves, Z. Huang, M. Fei, J. Voyvodic, C. Petty, M. Lutz, N. Bukhari-Parlakturk (Durham, USA)

    Objective: The primary objective of this study was to identify the brain regions contributing to dysfluent writing behavior in a subtype of dystonia called writer’s…
  • 2024 International Congress

    Study of Relationship Between Homocysteine, Folic Acid And Vitamin B12 Levels In Serum of Juvenile HD Children.

    A. Kumar, P. Mishra (Delhi, India)

    Objective: Our objective is to estimate the level of Hcy ,vitamin B12 , folic acid with motor and non-motor symptoms in HD patients in school…
  • 2024 International Congress

    Clinical and Epidemiological Aspects of Neuropsychiatric Features in Patients with Huntington Disease in Chile

    J. Fuentes, P. Salles, P. Chaná-Cuevas, C. Montalva, M. Sánchez, N. Rojas (Santiago, Chile)

    Objective: To describe the prevalence of motor and neuropsychiatric symptoms in HD patients seen at the Center of Movement Disorders (CETRAM), Santiago, Chile. Background: There…
  • 2024 International Congress

    Clinico- radiological profile of four patients with CSF1R- related leukoencephalopathy: A case series from India

    R S. Harishma, N. Kamble, P. Pal, V V. Holla, R. Yadav, S. Prasad (Bengaluru, India)

    Objective: We aimed to describe the clinical, radiological and genetic profile of patients with CSF1R- related leukoencephalopathy. Background: CSF1R- related leukoencephalopathy is a rare dominantly…
  • 2024 International Congress

    The Neuroprotective Effects of Rolipram, a Selective Phosphodiesterase IV Inhibitor, on Parkinson’s Disease in Rat Models: A Pharmacological Exploration in both In vivo and In vitro Settings

    R. Kumar, A. Kanojia (Darbhanga, India)

    Objective: Our research sought to unravel the pharmacological effects and mechanisms of action of Rolipram through both in vivo and in vitro experimentation in models…
  • 2024 International Congress

    Neuroprotective Efficacy of Ethanolic Extract from Amorphophallus Paeoniifolius Tuber Against Haloperidol-Induced Parkinson’s Disease Model

    R. Kumar, S. Choudhary (Handia,, India)

    Objective: This study aimed to evaluate the neuroprotective and antiparkinsonian effects of the ethanolic extract of Amorphophallus paeoniifolius tuber (APT) against haloperidol-induced Parkinson’s Disease (PD)…
  • 2023 International Congress

    Tramadol Induces Neuroinflammation, Mitochondrial Oxidative Stress, Neurotransmitters Dysbalanced and Produced Parkinson’s Disease Like Symptoms in Experimental Wistar Rats

    KHA. Aran (Moga, India)

    Objective: The current study is designed to evaluate the possible neurotoxic effects of tramadol in Wistar rats. Background: Parkinson’s disease (PD) is a chronic neurodegenerative…
  • 2023 International Congress

    Specific Parkinson’s disease phenotype in patients with long term PTSP

    I. šarac, H. šarac, N. Henigsberg, F. Borovečki, Z. Krešić, I. Ivek, T. Sukobljević (Zagreb, Croatia)

    Objective: to describe possibly specific clinical phenotype of PD patients who suffered from long-term postraumatic-stress-disorders (PTSD Background: There is enough evidence about the relationship between…
  • 1
  • 2
  • 3
  • …
  • 14
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley